0000902664-24-000903.txt : 20240201 0000902664-24-000903.hdr.sgml : 20240201 20240201164758 ACCESSION NUMBER: 0000902664-24-000903 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240130 FILED AS OF DATE: 20240201 DATE AS OF CHANGE: 20240201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HILLHOUSE INVESTMENT MANAGEMENT, LTD. CENTRAL INDEX KEY: 0001510589 ORGANIZATION NAME: STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41929 FILM NUMBER: 24587637 BUSINESS ADDRESS: STREET 1: OFFICE #122, WINDWARD 3 BUILDING STREET 2: REGATTA OFFICE PARK, WEST BAY ROAD CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-9006 BUSINESS PHONE: 345-749-8642 MAIL ADDRESS: STREET 1: OFFICE #122, WINDWARD 3 BUILDING STREET 2: REGATTA OFFICE PARK, WEST BAY ROAD CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-9006 FORMER NAME: FORMER CONFORMED NAME: HILLHOUSE CAPITAL MANAGEMENT, LTD. DATE OF NAME CHANGE: 20190510 FORMER NAME: FORMER CONFORMED NAME: Hillhouse Capital Management, Ltd. DATE OF NAME CHANGE: 20150109 FORMER NAME: FORMER CONFORMED NAME: Hillhouse Capital Management Pte. Ltd. DATE OF NAME CHANGE: 20150108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HHLR ADVISORS, LTD. CENTRAL INDEX KEY: 0001762304 ORGANIZATION NAME: STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41929 FILM NUMBER: 24587636 BUSINESS ADDRESS: STREET 1: OFFICE #122, WINDWARD 3 BUILDING STREET 2: REGATTA OFFICE PARK, WEST BAY ROAD CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-9006 BUSINESS PHONE: (345) 749-8643 MAIL ADDRESS: STREET 1: OFFICE #122, WINDWARD 3 BUILDING STREET 2: REGATTA OFFICE PARK, WEST BAY ROAD CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-9006 FORMER NAME: FORMER CONFORMED NAME: HILLHOUSE CAPITAL ADVISORS, LTD. DATE OF NAME CHANGE: 20190510 FORMER NAME: FORMER CONFORMED NAME: Hillhouse Capital Advisors, Ltd. DATE OF NAME CHANGE: 20181218 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ArriVent Biopharma, Inc. CENTRAL INDEX KEY: 0001868279 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18 CAMPUS BLVD. STREET 2: SUITE 100 CITY: NEWTOWN SQUARE STATE: PA ZIP: 19073-3269 BUSINESS PHONE: 240-780-6356 MAIL ADDRESS: STREET 1: 18 CAMPUS BLVD. STREET 2: SUITE 100 CITY: NEWTOWN SQUARE STATE: PA ZIP: 19073-3269 4 1 ownership.xml X0508 4 2024-01-30 0 0001868279 ArriVent Biopharma, Inc. AVBP 0001510589 HILLHOUSE INVESTMENT MANAGEMENT, LTD. OFFICE #122, WINDWARD 3 BUILDING REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-9006 CAYMAN ISLANDS 0 0 1 0 0001762304 HHLR ADVISORS, LTD. OFFICE #122, WINDWARD 3 BUILDING REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-9006 CAYMAN ISLANDS 0 0 1 0 0 Common Stock 2024-01-30 4 C 0 3616041 A 3616041 I See footnotes Common Stock 2024-01-30 4 C 0 313076 A 3929117 I See footnotes Common Stock 2024-01-30 4 P 0 555555 18.00 A 4484672 I See footnotes Series A Preferred Stock 2024-01-30 4 C 0 55000000 0 D Common Stock 3616041 0 I See footnotes Series B Preferred Stock 2024-01-30 4 C 0 4761903 0 D Common Stock 313076 0 I See footnotes Immediately prior to the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series B Preferred Stock converted into shares of common stock on a 15.21-for-1 basis. The securities reported herein are held by VSUM VI Holdings Limited ("VSUM VI") and VSUM VIII Holdings Limited ("VSUM VIII"). VSUM VI is a wholly owned subsidiary of Hillhouse Venture Fund V, L.P. ("Hillhouse Venture V") and VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare Fund, L.P. ("Hillhouse Healthcare"). HIM (as defined below) acts as the sole management company of each of Hillhouse Venture V and Hillhouse Healthcare. The securities reported herein are held by VSUM VIII and ARVT Holdings Limited ("ARVT"). VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare and ARVT is a wholly owned subsidiary of Hillhouse Venture Fund VI, L.P. ("Hillhouse Venture VI"). HIM acts as the sole management company of each of Hillhouse Healthcare and Hillhouse Venture VI. The securities reported herein are held by HHLR Fund, L.P., an exempted Cayman Islands limited partnership ("HHLR Fund"). HHLR (as defined below) acts as the sole management company of HHLR Fund. This statement is filed by (i) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company ("HIM") and (ii) HHLR Advisors, Ltd., an exempted Cayman Islands company ("HHLR"). The foregoing persons are hereinafter sometimes each referred to as a "Reporting Person" and collectively referred to as the "Reporting Persons." HIM and HHLR are under common control and share certain policies, personnel and resources. Accordingly, HIM and HHLR are filing this Form 4 jointly. The filing of this statement shall not be deemed an admission that each of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any. Hillhouse Investment Management, Ltd., by /s/ Audrey Woon, Chief Compliance Officer 2024-02-01 HHLR Advisors, Ltd. /s/ Audrey Woon, Chief Compliance Officer 2024-02-01